Skip to content

Sabra Healthcare SBRA Additional Paid-In Capital

Additional Paid-In Capital at other companies

American Healthcare REIT logo
American Healthcare REITAHR
$5.07B+34.4%
Welltower logo
WelltowerWELL
$52.41B+24.7%
Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
$8.78B+7.3%
NNN REIT logo
NNN REITNNN
$5.3B+1.9%
Healthpeak Properties logo
Healthpeak PropertiesDOC
$13.1B+2.1%
PACS Group logo
PACS GroupPACS
$646.74M+7.2%

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%
Enterprise value$4.46B+14.4%
P/E29.3×+1.4×
P/S5.6×+0.2×

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's additional paid-in capital?
Sabra Healthcare (SBRA) reported additional paid-in capital of $4.83B in Q1 2026.
How has Sabra Healthcare's additional paid-in capital changed year-over-year?
Sabra Healthcare's additional paid-in capital increased by 5.2% year-over-year, from $4.59B to $4.83B.
What is the long-term trend for Sabra Healthcare's additional paid-in capital?
Over 5 years (2020 to 2025), Sabra Healthcare's additional paid-in capital has grown at a 3.0% compound annual growth rate (CAGR), from $4.16B to $4.84B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.